Actinogen (ASX: ACW) will tomorrow begin independent pot trials to further test the performance of the previously discovered actinomycetes that produce plant growth hormones.
The trials will test the effectiveness of the growth hormones on wheat and peas, specifically measuring the amount of root, leaf and stem growth.
Actinogen completed initial pot trials on a series of actinomycetes in 2010 and 2011 which showed significant increased root growth and leaf and stem growth.
The new independent trials are being run for around six to seven weeks, with results to be available on conclusion of the trials.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.